A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PRM-151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS

Project: Other project

Project Details

StatusActive
Effective start/end date12/10/2011/30/23

Funding

  • Roche Laboratories Inc.: $10,109.23